Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Chinese Patent Office
Cantor Fitzgerald
Daiichi Sankyo
Chubb
Johnson and Johnson
Express Scripts
Federal Trade Commission

Generated: June 21, 2018

DrugPatentWatch Database Preview

PENLAC Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Penlac, and what generic alternatives are available?

Penlac is a drug marketed by Valeant Bermuda and is included in one NDA.

The generic ingredient in PENLAC is ciclopirox. There are ten drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.
Drug patent expirations by year for PENLAC
Synonyms for PENLAC
(6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone)
1-hydroxy-4-methyl-6-cyclohexyl-2-pyridone
19W019ZDRJ
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridone
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
2-azanylethanol;6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one
2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-
2(1H)-Pyridone, 6-cyclohexyl-1-hydroxy-4-methyl-
29342-05-0
342C050
6-Cyclohexenyl-1-hydroxy-4-methyl-2(1h)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one
6-CYCLOHEXYL-1-HYDROXY-4-METHYL-1H-PYRIDIN-2-ONE
6-Cyclohexyl-1-hydroxy-4-methyl-2-(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridinone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone #
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one
6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one
A819878
AB00053438_09
AB00053438_10
AB00053438_11
AB0011605
AB06517
AB2000628
AC-24195
AC1L1EDN
AJ-07970
AK544043
AKOS015895717
AN-773
Batrafen
Batrafen (TN)
Batrafen; Loprox;Mycoster;Stieprox;HOE 296b;Penlac
BC205517
BDBM66087
BG0571
BIDD:GT0080
BPBio1_000641
BSPBio_000581
BSPBio_002041
C-10474
C12H17NO2
CC-25776
CHEBI:453011
CHEMBL1413
CICLOPIROX
Ciclopirox (Penlac)
Ciclopirox (USP/INN)
Ciclopirox [USAN:BAN:INN]
Ciclopirox [USAN:USP:INN:BAN]
Ciclopirox gel
Ciclopirox Olamin
Ciclopirox-Olamin
Ciclopiroxum
Ciclopiroxum [INN-Latin]
cid_38911
CNL8
CS-2561
CTK4G3143
cyclopirox
cyclopyroxolamine
D03488
D07GRH
Dafnegin-CSC
DB01188
DR000350
DTXSID9048564
EINECS 249-577-2
FT-0602961
HE332472
HMS3656I12
HOE 296b
HOE-296
HOE-296b
HY-B0450
I06-0862
KB-270156
KBio3_001261
KBioGR_000816
KS-00000L3N
KS-5085
KSC563C4H
Loprox
Loprox (TN)
Loprox cream
Loprox Gel
Loprox Shampoo
LS-174247
MFCD00599441
MLS002153867
MolPort-003-845-943
Mycoster
NCGC00017112-04
NCGC00017112-05
NCGC00017112-06
NCGC00017112-08
NCGC00017112-11
NCGC00178850-01
NCGC00178850-02
Penlac (TN)
Penlac nail lacquer
Prestwick0_000541
Prestwick1_000541
Prestwick2_000541
Prestwick3_000541
s2528
SBI-0206690.P002
SC-17361
SCHEMBL34424
SCKYRAXSEDYPSA-UHFFFAOYSA-N
SMR001233223
SPBio_000252
SPBio_002502
Spectrum2_000146
Spectrum3_000351
Spectrum4_000288
Spectrum5_000747
SR-05000001589
SR-05000001589-5
Stieprox
Stieprox (TN)
Terit
TL8002303
UNII-19W019ZDRJ
W-106995
ZINC1145

US Patents and Regulatory Information for PENLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda PENLAC ciclopirox SOLUTION;TOPICAL 021022-001 Dec 17, 1999 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Merck
Daiichi Sankyo
Johnson and Johnson
McKinsey
Accenture
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.